Formation of reactive oxygen intermediates might be involved in the trypanocidal activity of gallic acid

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 6, 1998, Pages 583-587

  Nose, Mitsuhiko ^a   Koide, Tatsuo ^a   Morikawa, Kyoko ^a   Inoue, Makoto ^a   Ogihara, Yukio ^a   Yabu, Yoshisada ^b   Ohta, Nobuo ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

DNA strand breaking; ESR spin trapping; Gallic acid; Reactive oxygen intermediates (ROIs); Trypanocidal activity; Trypanosoma brucei brucei (GUTat 3.1 clone)

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; CATALASE; GALLIC ACID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG MECHANISM; DRUG STABILITY; ERYTHROCYTE SEDIMENTATION RATE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TRYPANOSOMA BRUCEI; TRYPANOSOMIASIS;

EID: 0031816772     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.583     Document Type: Article

References (23)

1. Koide T., Nose M., Inoue M., Ogihara Y., Yabu Y., Ohta N., Planta Med., 64, 27-30 (1998).
2. Opperdoes F. R., Borst P., Bakker S., Leene W., Eur. J. Biochem., 76, 29-39 (1977).
3. Clarkson A. B., Bienen E. J., Pollakis G., Grady R. W., J. Biol. Chem., 264, 17770-17776 (1989).
4. Grady R. W., Bienen E. J., Clarkson A. B., Jr. Mol. Biochem. Parasitol., 21, 55-63 (1986).
5. Meshnick S. R., Blobstein S. A., Grady R. W., Cerami A., J. Exp. Med., 148, 569-579 (1978).
6. Marklund S., Marklund G., Eur. J. Biochem., 47, 469-474 (1974).
7. Yabu Y., Southeast Asian J. Trop. Med. Public Health. 24, 706-711 (1993).
8. Clarkson A. B., Jr., Brohn F. H., Science, 194, 204-206 (1976).
9. Minagawa N., Yabu Y., Kita K., Nagai K., Ohta N., Meguro K., Sakajo S., Yoshimoto A., Mol. Biochem. Parasitol., 84, 271-280 (1997).
10. Saprin A. N., Piette L. H., Arch. Biochem. Biophys., 180, 480-492 (1977).
11. Buettner G. R., Free Rad. Biol. Med., 3, 259-303 (1987)
12. Hiramoto K., Ojima N., Sako K., Kikugawa K., Biol. Pharm. Bull., 19, 558-563 (1996).
13. Johnson P. H., Grossman L. I., Biochemistry, 16, 4217-4224 (1977).
14. Gichner T., Pospisil F., Veleminsky V., Volkeova V., Volke J., Folia Microbiol., 32, 55-62 (1987).
15. Huang M. T., Chang R. L., Wood A. W., Newmark H. L., Sayer J. M., Yagi H., Jerina D. M., Conney A. H., Carcinogenesis, 6, 237-242 (1985).
16. Mirvish S. S., Cardesa R. L., Wallcave L., Shubik P., J. Natl. Cancer Inst., 55, 633-636 (1975).
17. de Peyster A., Quintanilha A., Packer L., Smith M. T., Biochem. Biophys. Res. Commun., 118, 573-579 (1984).
18. Srivastava A. K., Radmanaban G., Biochem. Biophys. Res. Commun., 146, 1515-1522 (1987).
19. Shiraha S., Murakami H., Nishiyama K., Sugata I., Shinohara K., Nonaka G., Nishioka I., Omura H., Agric. Biol. Chem., 49, 1033-1040 (1985).
20. Hodnick W., Kung F. S., Roettger W. J., Bohmont C. W., Pardini R. S., Biochem. Pharmacol., 38, 2859-2865 (1989)
21. Laughton M. J., Halliwell B., Evans P. J., Hoult J. R. S., Biochem. Pharmacol., 38, 2859-2865 (1989)
22. Canada A. T., Giannella E., Nguyen T. D., Mason R. P., Free Rad. Biol. Med., 9, 441-449 (1990).
23. Sakagami H., Satoh K., Hatano T., Yoshida T., Okuda T., Anticancer Res., 17, 377-380 (1997).